Pharmacotherapy and the risk for community-acquired pneumonia.
about
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal diseaseChoice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-upRisk factors associated with lower defecation frequency in hospitalized older adults: a case control studyManaging the safety of inhaled corticosteroids in COPD and the risk of pneumonia.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Recurrent pneumonia among Japanese adults: disease burden and risk factors.Geographic variation in outpatient antibiotic prescribing among older adults.Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors.Antipsychotic drug use and community-acquired pneumoniaRisk-to-benefit ratio of inhaled corticosteroids in patients with COPD.Adverse drug events as a cause of hospitalization in older adults.Indications and safety of proton pump inhibitor drug use in patients with cancer.Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study.Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies.Comparative safety of atypical antipsychotics and the risk of pneumonia in the elderly.Hypoalbuminemia, influenza vaccination and other factors related to the development of pneumonia acquired outside hospitals in southern Japan: A case-control study.Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.Periodontal infections and community-acquired pneumonia: a case-control study.Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study.Antipsychotics and the Risk of Aspiration Pneumonia in Individuals Hospitalized for Nonpsychiatric Conditions: A Cohort Study.Uses of proton pump inhibitors and hypomagnesemia.Nurse-led medicines' monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines
P2860
Q26798305-E50B0E39-7E8F-4D15-8B5E-5EE7DB7CA3A5Q34298335-B9D231EF-5EB9-4FFA-A164-E3D21F079531Q34479280-641CD70B-30BD-4FF8-BA5C-C39E97E2F489Q35008414-CF66D763-7146-4FED-88D6-BC81B0BC24BFQ35427329-868F5913-3D33-48DD-858B-2CBF0D4DA911Q35675040-CBCCB36F-3646-4382-B90D-3D0D81554734Q35754726-46AF8792-535D-481A-B539-0A753E97D11BQ36246696-1E706251-006F-42C7-97CB-C3BB80C75E7AQ36489890-86B1E496-FB91-40D6-A712-7A494EC156D0Q36603193-C6BE98D8-4C5D-48A1-AAB1-3DC1073CC167Q37851853-2BC67BB1-B58B-4323-91C6-D3617B87AAE5Q38058413-7379303A-A37B-4E5A-B1A9-1E46D14EA845Q38085222-D53EAE2B-3535-42E3-95E4-44A139C4DB62Q38104388-8ED3A793-456B-4CC8-B9A4-AB828B40E6A6Q38214498-15C063BD-5609-4F30-8E05-223B53C88C7CQ38285835-DDD55422-895C-4B69-A9FB-6D56567F5C24Q38366274-97E6773F-B715-4472-9908-0713183073EAQ38504536-7F812617-2228-4376-891F-B2EDB305E696Q38601671-E5253E93-836A-4624-96E9-D515072462CBQ41499977-B743AE5E-DBB0-43A9-B259-9CDD77299671Q44175464-9A63AAF3-551A-478A-A83D-E69E9A690D73Q45281165-218F4CE8-BEF6-41E0-B64C-283EFB8672A7Q47601045-E755DDEC-B857-480A-982E-C295C204088AQ47622699-614CF35C-4753-418D-B4F0-B81EA363BB9BQ53663004-3C68FB68-72B3-4455-92A7-E68DD43D77E0Q59125704-25656A17-1E7A-4205-B7BC-C61542AA5128
P2860
Pharmacotherapy and the risk for community-acquired pneumonia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacotherapy and the risk for community-acquired pneumonia.
@ast
Pharmacotherapy and the risk for community-acquired pneumonia.
@en
type
label
Pharmacotherapy and the risk for community-acquired pneumonia.
@ast
Pharmacotherapy and the risk for community-acquired pneumonia.
@en
prefLabel
Pharmacotherapy and the risk for community-acquired pneumonia.
@ast
Pharmacotherapy and the risk for community-acquired pneumonia.
@en
P2093
P2860
P356
P1433
P1476
Pharmacotherapy and the risk for community-acquired pneumonia
@en
P2093
Jen-Tzer Gau
Salman Khan
Tzu-Cheg Kao
Victor Heh
P2860
P2888
P356
10.1186/1471-2318-10-45
P577
2010-07-06T00:00:00Z
P5875
P6179
1039106525